RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
A layman's look at ONC & Multiple Myeloma. In numerical order from clinical trials.gov.
6. Ambush - Not yet recruiting. Adding Keytruda.
7. Celgene Trial Status Unknown, this would have fallen under the aegis of BMS presumably.
10. NCI Reolysin Complete
11. NCI/ONC Reovirus and Bortezomib. This trial presumably led to AMBUSH in which Keytruda will be added.
12. NCI Carfilzomib. Active. not recruiting.
22. BMS Trial adding Nivolumab to carfilzomib
There seems to be connectivity, and a lot of interest in MM
I guess I am wondering if elranatamab fits anywhere. There has also been other MM work.
TIA